Stay updated on Belantamab Combo in Lenalidomide Refractory MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab Combo in Lenalidomide Refractory MM Clinical Trial page.

Latest updates to the Belantamab Combo in Lenalidomide Refractory MM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s footer shows an updated ClinicalTrials.gov site revision from v3.5.2 to v3.5.3, a change limited to the platform/version label rather than the trial information itself.SummaryDifference0.1%

- Check22 days agoChange DetectedAdded Revision: v3.5.2. Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision v3.5.0 added and Revision v3.4.3 removed from the study's record history.SummaryDifference0.1%

- Check59 days agoChange DetectedA new revision entry (v3.4.3) was added and the previous revision (v3.4.2) was removed from the record history.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision v3.4.2 was added to the record history, and the previous funding notice and revision v3.4.1 were deleted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check94 days agoChange DetectedAdded a site-wide funding notice and updated the page revision from v3.4.0 to v3.4.1; these changes do not modify the study record or its history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

Stay in the know with updates to Belantamab Combo in Lenalidomide Refractory MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Combo in Lenalidomide Refractory MM Clinical Trial page.